The increasing mortality burden of liver disease among opioid-dependent people: cohort study - PubMed (original) (raw)
The increasing mortality burden of liver disease among opioid-dependent people: cohort study
Amy Gibson et al. Addiction. 2011 Dec.
Abstract
Aims: Hepatitis C (HCV) infection is highly prevalent among injection drug users (IDUs) and likely to cause significant mortality over time, but little research attention has focused upon the magnitude of this risk, particularly among ageing users. This study examined trends over time in mortality attributed to liver disease, and in particular contrasting this with other more commonly studied causes of death [acquired immune deficiency syndrome (AIDS), suicide and overdose] among an ageing cohort of heroin-dependent people in Australia.
Design: Data linkage study of methadone treatment entrants with the National Deaths Index.
Setting: A cohort entering methadone treatment for heroin dependence in New South Wales, Australia, 1980-85.
Participants: A total of 2489 people entering methadone treatment for heroin dependence and 54,847 person-years (PY) of follow-up.
Measurements: Linkage of data on all methadone entrants between 1980 and 1985 with data from the Australian National Deaths Index, linked using probabilistic record linkage software.
Findings: There were 8.2 deaths per 1000 PY [95% confidence interval (CI) 7.5-9.0], with standardized mortality ratios (SMRs) of 4.6 (95% CI 4.2-5.0). Almost one in five (17%) of deaths were from underlying liver-related causes, most commonly viral hepatitis. The overall mortality rate for any liver cause was 1.4 deaths per 1000 PY (95% CI 1.1-1.7), 17 times higher than to the general population (95% CI 13.4-21.3), with relative elevations more marked for females (SMR 27.9; 95% CI 17.7-41.9) than males (SMR 14.5; 95% CI 10.8-19.0). Liver mortality increased over time, becoming the most common cause of death by the end of follow-up.
Conclusions: Liver disease has become the most common cause of mortality among ageing opioid-dependent people in an ageing Australian cohort. There is an imperative to reduce the long-term risks of HCV and other risks to the liver, including alcohol consumption, which are typically not the major clinical focus for this group.
© 2011 The Authors, Addiction © 2011 Society for the Study of Addiction.
Comment in
- Commentary on Gibson et al. (2011): Brief alcohol interventions in the context of treatment for hepatitis C.
Cucciare MA, Weingardt KR. Cucciare MA, et al. Addiction. 2011 Dec;106(12):2193-4. doi: 10.1111/j.1360-0443.2011.03603.x. Addiction. 2011. PMID: 22049985 No abstract available.
Similar articles
- The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent people.
Larney S, Randall D, Gibson A, Degenhardt L. Larney S, et al. Drug Alcohol Depend. 2013 Aug 1;131(3):252-7. doi: 10.1016/j.drugalcdep.2012.11.012. Epub 2012 Dec 10. Drug Alcohol Depend. 2013. PMID: 23237980 - Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
Brugal MT, Domingo-Salvany A, Puig R, Barrio G, García de Olalla P, de la Fuente L. Brugal MT, et al. Addiction. 2005 Jul;100(7):981-9. doi: 10.1111/j.1360-0443.2005.01089.x. Addiction. 2005. PMID: 15955014 - Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.
Stoové MA, Dietze PM, Jolley D. Stoové MA, et al. Drug Alcohol Rev. 2009 Jul;28(4):347-52. doi: 10.1111/j.1465-3362.2009.00057.x. Drug Alcohol Rev. 2009. PMID: 19594787 - Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.
Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J. Degenhardt L, et al. Addiction. 2011 Jan;106(1):32-51. doi: 10.1111/j.1360-0443.2010.03140.x. Epub 2010 Nov 4. Addiction. 2011. PMID: 21054613 Review. - Fatal heroin 'overdose': a review.
Darke S, Zador D. Darke S, et al. Addiction. 1996 Dec;91(12):1765-72. doi: 10.1046/j.1360-0443.1996.911217652.x. Addiction. 1996. PMID: 8997759 Review.
Cited by
- A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder.
Miller JC, Brooks MA, Wurzel KE, Cox EJ, Wurzel JF 3rd. Miller JC, et al. Drugs R D. 2023 Dec;23(4):339-362. doi: 10.1007/s40268-023-00443-5. Epub 2023 Nov 8. Drugs R D. 2023. PMID: 37938531 Free PMC article. Review. - Factors associated with suicide in people who use drugs: a scoping review.
Devin J, Lyons S, Murphy L, O'Sullivan M, Lynn E. Devin J, et al. BMC Psychiatry. 2023 Sep 5;23(1):655. doi: 10.1186/s12888-023-05131-x. BMC Psychiatry. 2023. PMID: 37670233 Free PMC article. - Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia.
Chaillon A, Bharat C, Stone J, Jones N, Degenhardt L, Larney S, Farrell M, Vickerman P, Hickman M, Martin NK, Bórquez A. Chaillon A, et al. Addiction. 2022 May;117(5):1338-1352. doi: 10.1111/add.15736. Epub 2021 Dec 4. Addiction. 2022. PMID: 34729841 Free PMC article. - A cohort study revealed high mortality among people who inject drugs in Hai Phong, Vietnam.
Vinh VH, Vallo R, Giang HT, Huong DT, Oanh KTH, Khue PM, Thanh NTT, Quillet C, Rapoud D, Michel L, de Perre PV, Feelemyer J, Moles JP, Cournil A, Jarlais DD, Laureillard D, Nagot N. Vinh VH, et al. J Clin Epidemiol. 2021 Nov;139:38-48. doi: 10.1016/j.jclinepi.2021.07.007. Epub 2021 Jul 16. J Clin Epidemiol. 2021. PMID: 34280476 Free PMC article. - Mortality among amphetamine users with hepatitis C virus infection: A nationwide study.
Gahrton C, Håkansson A, Kåberg M, Jerkeman A, Häbel H, Dalgard O, Duberg AS, Aleman S. Gahrton C, et al. PLoS One. 2021 Jun 24;16(6):e0253710. doi: 10.1371/journal.pone.0253710. eCollection 2021. PLoS One. 2021. PMID: 34166475 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical